Sopheon, a provider of software, expertise and best practices for Enterprise Innovation Performance, has been awarded European funding for research in the framework of the EUREKA/ITEA research programme alongside a consortium of project partners.
The funding is for two different projects: Medolution and PARTNER.
Both research projects focus on developing innovative and intelligent methods and software for real time handling of massive volumes of data across complex scenarios, with emphasis on the healthcare industry.
Sopheon's contribution to these projects focuses on applying the data-driven decision support capabilities of its Accolade software.
Sopheon benefits in return from the collaboration with project partners - research institutes and leading software companies such as Philips Healthcare, Atos/Bull, Siemens Healthcare, Barco, IMEC, KPN and NXP Semiconductors - to develop breakthrough capabilities for commercial application in its software.
Huub Rutten, VP research and application development at Sopheon, stated: "For Sopheon the research is very applicable to our core enterprise innovation management clients and future product strategy. Our work in these projects positions us to develop relationships with some of the leading companies in the world for commercial leverage, and to develop innovative strategic technologies and applications for our target markets. Further, our research discoveries also have the potential to open new market segments for our application."
This award brings to a total of five the number of research grants awarded to Sopheon since 2009.
At 9:44am: (LON:SPE) Sopheon PLC share price was +10p at 402.5p